SCHEMBL23129804

SCHEMBL23129804

CC1CC(Br)=CC=C1NC(=O)NN1C(=O)NC(C)(CCc2ccco2)C1=O

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14945859 0.82 FPR2 (1.00) FPR2
SCHEMBL14945860 0.77 FPR2 (0.74) FPR2
SCHEMBL20882680 0.73 FPR2 (0.82) FPR2
SCHEMBL22622493 0.70 FPR2 (0.60) FPR2
SCHEMBL14935397 0.67 FPR2 (1.00) FPR2
SCHEMBL23129837 0.66 FPR2 (0.67) FPR2
SCHEMBL22506224 0.66 FPR2 (1.00) FPR2
SCHEMBL14945864 0.66 FPR2 (1.00) FPR2
SCHEMBL14945787 0.66 FPR2 (0.54) FPR2
SCHEMBL14935725 0.65 FPR2 (0.80) FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795148-A1 USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR INFLAMMATORY DISEASES ALLERGAN, INC. (US) 2021-03-24 EP disclosed